New Insomnia Treatment Approved

January 16, 2020

New Insomnia Treatment Approved

Orexin receptor antagonist DAYVIGO TM has been approved for the treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance in adults. The medication was tested in 2,000 patients before being approved by the FDA. Clinical trials are much more than just a drug, patient and a placebo, which is why Yourway offers ancillary material sourcing, including medical equipment and devices as well as diagnostic and testing equipment.

Back to Index

Media

Upcoming Event

Clinical Trial Supply Europe

March 11-12, 2020
Madrid, Spain
Booth #54

Schedule a Meeting

Media

Articles

Agility and Flexibility in a Company That Provides Both Courier and Clinical Packaging Services